Corbus Pharmaceuticals Holdings (CRBP) Operating Leases (2018 - 2025)

Corbus Pharmaceuticals Holdings' Operating Leases history runs 8 years deep, the most recent figure standing at $307000.0 for Q3 2025.

• In Q3 2025, Operating Leases fell 85.01% year-over-year to $307000.0; the TTM figure through Sep 2025 stood at $307000.0 (down 85.01% YoY), while the FY2024 annual figure was $1.6 million, down 49.58% from the prior year.
• Operating Leases was $307000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, down from $761000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $6.8 million in Q1 2021 to a low of $307000.0 in Q3 2025.
• Historically, Operating Leases has averaged $3.8 million across 5 years, with a median of $4.0 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Operating Leases fell 16.03% in 2021, then tumbled 85.01% in 2025.
• A 5-year view of Operating Leases shows it stood at $6.0 million in 2021, then retreated by 21.5% to $4.7 million in 2022, then sank by 30.72% to $3.2 million in 2023, then tumbled by 49.58% to $1.6 million in 2024, then sank by 81.2% to $307000.0 in 2025.
• The last three Operating Leases figures came in at $307000.0 (Q3 2025), $761000.0 (Q2 2025), and $1.2 million (Q1 2025), per Business Quant data.